Experienced in Mitochondrial Complex 1 Deficiency

Dan C. Tao

Hubei Province Key Laboratory Of Occupational Hazard Identification And Control, 
Wuhan, CN 
Experienced in Mitochondrial Complex 1 Deficiency
Hubei Province Key Laboratory Of Occupational Hazard Identification And Control, 
Wuhan, CN 
OverviewLocationsClinical Research

Overview

Dan Tao practices in Wuhan, China. Mr. Tao is rated as an Experienced expert by MediFind in the treatment of Mitochondrial Complex 1 Deficiency. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Bladder Cancer, and Cerebral Hypoxia.

His clinical research consists of co-authoring 84 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Mitochondrial Complex 1 Deficiency.

Gender
Male

Locations

Hubei Province Key Laboratory Of Occupational Hazard Identification And Control, Wuhan, 430065, China
Other Locations
Nanchang, China
Chongqing, China
The Key Laboratory Of Environmental Pollution Monitoring And Disease Control, No.6 Ankang Road, Guian New Area, 561113, China
The Key Laboratory Of Environmental Pollution Monitoring And Disease Control, No.6 Ankang Road, Guian New Area, Guiyang, 561113, China
181 Hanyu Road, Tanjiagang, 400030, China
Beijing, 100044, China
Chengdu, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

84 Total Publications

Correction: Tao et al. Development of a Label-Free Electrochemical Aptasensor for the Detection of Tau381 and its Preliminary Application in AD and Non-AD Patients' Sera. Biosensors 2019, 9, 84.
Correction: Tao et al. Development of a Label-Free Electrochemical Aptasensor for the Detection of Tau381 and its Preliminary Application in AD and Non-AD Patients' Sera. Biosensors 2019, 9, 84.
Journal: Biosensors
Published: March 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tao's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile